A Category-Free Approach to Prognostic Modelling in Aggressive Non-Hodgkin B Cell Lymphomas Based on Large Patient Databases

Hematological Oncology - United Kingdom
doi 10.1002/hon.2439_70
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Prognostic Factors in Aggressive Non‐Hodgkin's Lymphomas

Oncologist
Cancer ResearchMedicineOncology
1998English

Diffuse Large B-Cell Lymphoma: A Heterogeneous Group of Non-Hodgkin Lymphomas Comprising Several Distinct Clinicopathological Entities

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2006English

A Study of the Newer Prognostic Markers in Diffuse Large B Cell Lymphomas

Medical Journal Armed Forces India
Medicine
2011English

Constitutive Overexpression of a Novel 21 kDa Protein by Hodgkin Lymphoma and Aggressive Non-Hodgkin Lymphomas

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2008English

A Large Single-Institution Retrospective Analysis of Aggressive B-Cell Lymphomas According to the 2016/2017 WHO Classification

Advances in Clinical and Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
2019English

Lenalidomide in Diffuse Large B-Cell Lymphomas

Advances in Hematology
Hematology
2012English

Clinical Interest of LMO2 Testing for the Diagnosis of Aggressive Large B-Cell Lymphomas

Cancers
Cancer ResearchOncology
2020English

Prognostic Significance of in Situ Phenotypic Marker Expression in Diffuse Large B-Cell Lymphomas

Biomarker Insights
BiochemistryMolecular MedicinePharmacology
2007English

Microenvironment Expression in Diffuse Large B-Cell Lymphomas

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy